FREMONT, Calif., March 23 /PRNewswire-FirstCall/ -- Abgenix, Inc.
(Nasdaq: ABGX) today announced that it will present at the Smith Barney
Citigroup 2005 Healthcare Conference on Wednesday, March 30, 2005 at 6:45 a.m.
PT / 9:45 a.m. ET. The presentation will be webcast live and may be accessed
by visiting the Abgenix website at http://www.abgenix.com. A replay of the webcast
will also be available on the company's website until Wednesday, April 13,
2005.
Dr. Gisela Schwab, chief medical officer of Abgenix, will provide an
update on the company's antibody drug development activities.
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery,
development and manufacturing of human therapeutic antibodies. The company's
antibody development platform includes a leading technology and
state-of-the-art manufacturing capabilities that enable the rapid generation,
selection and production of high affinity, fully human antibody product
candidates to a variety of disease targets. Abgenix leverages its leadership
position in human antibody technology to build a diversified product portfolio
through the establishment of collaborations with multiple pharmaceutical and
biotechnology companies. For more information on Abgenix, visit the company's
website at http://www.abgenix.com.
SOURCE Abgenix, Inc.
 back to top
Related links:
http://www.abgenix.com
CONTACT:
Ami Knoefler, Senior Director, Corporate
Communications and Investor Relations of Abgenix, Inc.,
+1-510-284-6350, or +1-510-284-6605
|
